A specific list of high-priority projects ( The OMI-MERIT Initiative), focused on finding diagnostic tools and treatments, including a Rituxan clinical trial, was created and agreed upon by a global consortium of world renowned researchers and clinicians including, in alphabetical order, Drs. Lucinda Bateman, Yenan Bryceson, Ron Davis, David Dreyfus, Oystein Fluge, Mady Hornig, Nancy Klimas, Andy Kogelnik (Chair), Charles Lapp, Jay Levy, Alan Light, Kathleen Light, Sonya Marshall, Mauro Malnati, Olav Mella, Jose Montoya, Dan Peterson, Simone Pensieroso, Ila Singh, Carmen Scheibenbogen, Charles Shepherd, and Rozamond Vallings. NIDA is collaborating with the Open Medicine Institute (OMI) and all monies raised as part of the Chase-sponsored contest will support the OMI-MERIT Initiative. The goals are to fast-track answers in diagnosis and treatment. For more information please visit www.openmedicineinstitute.org.www.nidalliance.org/ways-to-help.html
Chat about this charity
To add a comment, you must vote for this charity first.
If this page contains objectionable content, or you feel it otherwise violates the Program Rules, please let us know.